A GHRH-analog peptide, the same compound class as an approved pharmaceutical product, sold in the research-chemical retail market. The Peptide Index files it under Growth-hormone secretagogue.
As of Sep 25, 2026, the lowest listed price is $2.88/mg and the median current listing is $8.00/mg, across 122 vendors (195 comparable single-compound listings). Prices are normalized to US dollars per milligram of peptide, exclude shipping, and are refreshed nightly.
In the nightly price history, the daily median fell from $10.00/mg on Jul 14, 2026 to $8.50/mg on Sep 25, 2026 (−15.0%), based on 67 observed days. Days the crawl missed are left out, not filled in. The daily series is taken across each day’s comparable listings, so it can differ slightly from the current-listings median above. See the full Tesamorelin price history chart.
| Vendor | $/mg | Price (USD) | Package |
|---|---|---|---|
| Skye Peptides | $2.88/mg | $69.00 | 24mg vial |
| Rarev Biolabs | $3.33/mg | $100.00 | 30mg vial |
| Labrat Peptides | $3.60/mg | $72.00 | 20mg vial |
| Aura Research Peptides | $4.00/mg | $40.00 | 10mg vial |
| Crush Research | $4.00/mg | $80.10 | 20mg vial |
Each vendor name links to its public-record trust profile. The Tesamorelin price page lists every current listing.
Every night The Peptide Index reads vendors’ public catalog pages, records the listed price and stated peptide content, and divides one by the other to get a comparable $/mg. Blends and topical/cosmetic products are excluded from single-compound figures. Read the full methodology and how vendor signals are checked.